OVERVIEW

Continuing our dedication to providing a comprehensive and current update in the management of thyroid disease, USC presents the Peter A. Singer Thyroid Symposium in 2023.
This is again a hybrid program, offering options for either an in-person experience or virtual attendance. Clinical care of patients with thyroid disorders is a changing and increasingly complex practice.  We will present forward-looking perspectives on the most current state of thyroid medicine informed by evidenced-based management strategies.
For 2023, we will highlight key areas of advancement and interest to both specialists and general providers, including subclinical hypothyroidism, optimizing your ultrasound assessment of nodules, postpartum thyroid disease, radioactive iodine use in the treatment of thyroid cancer, voice complaints after thyroidectomy, and more.  Presentations combining evidence-based medicine, clinical experience, challenging cases, panel discussions, and audience questions will help inform solutions to complex clinical scenarios.

LEARNING OBJECTIVES

By the end of the course, participants will be able to:

• Decide evidenced-based approach to patients with subclinical hypothyroidism.
• Examine ultrasound features of thyroid nodules and assess malignancy risk and indication for fine-needle aspiration biopsy.
• Select radioactive iodine treatment for patients with thyroid cancer based on current evidenced-based understanding of risk and benefits.
• Discuss the current use and limitations of thyroglobulin measurement for patients with differentiated thyroid cancer after hemithyroidectomy.
• Determine management for toxic thyroid nodules.
• Identify common vocal complaints after thyroidectomy and available treatments.
• Review the clinical indications and available systematic therapy options for patients with advanced thyroid cancers.
• Provide appropriate postpartum management of common thyroid conditions.

TARGET AUDIENCE

This course is intended for endocrinologists, primary care providers, nurses and other allied health professionals. Head and Neck or Endocrine surgeons, and trainees seeking to enhance their understanding of thyroid diseases and treatment options in order to select optimal management for their patients. 

ACCREDITATION

The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 5.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.